PharmaEngine, Inc.(TW:4162)
NT$52.50-0.30 (-0.57%)
TW:4162
PharmaEngine, Inc. financials statements
NT$52.50
At close:-0.30 (-0.57%)
PharmaEngine, Inc. (4162) Financial Statements
PharmaEngine, Inc. Financial Overview
PharmaEngine, Inc.'s market cap is currently NT$7.43B. The company's EPS TTM is NT$3.75; its P/E ratio is 14.16; and it has a dividend yield of 3.81%. PharmaEngine, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 911.42M | NT$ 2.52B | NT$ 767.67M | NT$ 654.38M | NT$ 654.84M |
| Gross Profit | NT$ 849.51M | NT$ 2.48B | NT$ 718.97M | NT$ 604.68M | NT$ 617.76M |
| Operating Income | NT$ 425.46M | NT$ 2.05B | NT$ 277.18M | NT$ 282.75M | NT$ 362.47M |
| EBITDA | NT$ 519.48M | NT$ 2.17B | NT$ 347.31M | NT$ 401.15M | NT$ 555.87M |
| Net Income | NT$ 387.64M | NT$ 1.75B | NT$ 274.65M | NT$ 318.78M | NT$ 426.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 4.72B | NT$ 3.86B | NT$ 3.63B | NT$ 3.66B | NT$ 3.81B |
| Total Assets | NT$ 5.15B | NT$ 5.85B | NT$ 3.95B | NT$ 3.97B | NT$ 4.03B |
| Total Debt | NT$ 42.12M | NT$ 7.14M | NT$ 14.81M | NT$ 22.35M | NT$ 7.59M |
| Net Debt | NT$ -1.54B | NT$ -986.56M | NT$ -860.81M | NT$ -1.75B | NT$ -2.14B |
| Total Liabilities | NT$ 221.59M | NT$ 448.01M | NT$ 91.01M | NT$ 94.47M | NT$ 87.70M |
| Stockholders' Equity | NT$ 4.93B | NT$ 5.40B | NT$ 3.86B | NT$ 3.87B | NT$ 3.94B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 1.73B | NT$ 455.32M | NT$ 256.56M | NT$ 198.07M | NT$ 929.44M |
| Operating Cash Flow | NT$ 1.73B | NT$ 456.73M | NT$ 256.97M | NT$ 202.01M | NT$ 929.67M |
| Investing Cash Flow | NT$ -266.65M | NT$ -115.54M | NT$ -855.48M | NT$ -188.12M | NT$ -107.00M |
| Financing Cash Flow | NT$ -870.37M | NT$ -223.11M | NT$ -294.73M | NT$ -395.71M | NT$ -507.00M |
Currency in TWD
